Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  -153.50p -3.86% 3,821.50p 9,679,015 16:35:17
Bid Price Offer Price High Price Low Price Open Price
3,834.50p 3,838.00p 3,946.00p 3,744.00p 3,800.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 11,224.6 3,149.2 348.7 11.4 34,759.69

Shire (SHP) Latest News (62)

More Shire News
Shire Takeover Rumours

Shire (SHP) Share Charts

1 Year Shire Chart

1 Year Shire Chart

1 Month Shire Chart

1 Month Shire Chart

Intraday Shire Chart

Intraday Shire Chart

Shire (SHP) Discussions and Chat

Shire Forums and Chat

Date Time Title Posts
22/4/201800:45ADDERALL XR sales boost Shire3,111
19/4/201822:57SHIRE Pharmaceuticals847
15/2/201722:25Time to Look at Shire (SHP)-
03/12/201621:04Analysts' Perspective on Shire (SHP)-
29/8/201618:22New Opportunity for Shire (SHP)-

Add a New Thread

Shire (SHP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Shire trades in real-time

Shire (SHP) Top Chat Posts

Shire Daily Update: Shire Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SHP. The last closing price for Shire was 3,975p.
Shire Plc has a 4 week average price of 2,944p and a 12 week average price of 2,940.50p.
The 1 year high share price is 5,021p while the 1 year low share price is currently 2,940.50p.
There are currently 909,582,311 shares in issue and the average daily traded volume is 7,870,484 shares. The market capitalisation of Shire Plc is £34,759,688,014.87.
mbmiah: The market doesn't believe the bod will accept the bid hence the lower share price. Once there is indication of acceptance or a rival bidder then the share price will rocket. Place your sell orders boys!!!
justiceforthemany: Shorters will be all over the new company if formed due to the massive debt. Shire has about $20Bn in debt. This was the main drag on Shire's share price and why it has slumped 30% in the past 12 months. No position in Takeda but really seems like a bad and brainless move on their part. Their own share price has been decimated and they seem desperate.
paa65: Could Allergan be playing a smart game here?Avoid the bidding war. Let Takeda make a last bid (probably rejected again).See SHP share price fall again.And then come in with a better cash offer?
scothernman: Can those with experience please enlighten us what happens for example if the revised bid is for £50 and £20 is paid in cash and £30 in takeda shares, if one holds 1000 shares of SHP currently. 1. What may the marketmakers value SHP in such a scenario as it is not all cash I i.e., share price next Friday? 2. if takeda shares value drops further what may be the true value (educated guess) of SHP after takeover. 3. How long it may take for takeda to list on UK stock exchange to sell the new shares you have acquired? Thanks for your replies.
karateboy: Two consecutive days share price dropped when USA market opened few days ago. Trend reversed now and Last two days share price moving higher after 15:00. Takeda CEO is reported visiting USA this week may be causing it or there is another bidder getting ready to join in. Hopefully share price will be £40 before any bidding starts. Big volume today almost twice the average daily trades and share price moves higher. That is good
blueclyde: Given how leaky this share has been based on the share price movements prior to news being released Takeda would have known this sale was happening I presume as it didn't just happen over night. Whilst having little impact on the share price it may make a take over even likely as there is now a couple of billion cash on the balance sheet which can quickly be leveraged in a takeover situation. I am guessing that the sale came about because a few months back there were also vultures circling. You can't argue that the balance sheet and valuation metrics here all look very healthy which would support a highly geared takeover if needed.
adamb1978: Does feel like an offer will be made at some point - whether its at a price which SHP would recommend or not though, I'm somewhat sceptical. Could potentially get into a situation where Takeda go to SHP's investors and try to strong arm management into a deal, and we see a couple increased offers. Even if it were rebuffed though, it would provide some pep to the share price, even after it was rejected. Also, can completely understand the comments that a lot of investors would take £45 per share. The share price has only be heading in one direction and the opportunity to take something like a 50% premium to where the price was prior to the speculation is something which financial investors would readily accept I feel.
karateboy: Let's summarise what we know and what happens if take over is successful: 1. In 2014 a $54b takeover of SHP by Abbvie was called off due US tax rule. Is Abbvie still interested? 2. In 2016 SHP paid $32b for Baxalta..share price decline started then. However current share price does not give any value to this take over. 3. SHP and Tekeda combined will creat one of the biggest Pharma with revenue of $30b . I wonder if other big Pharma will let this to happen. So if Takeda makes the move, I believe other big Pharma may join the bid... 4. Takeda has no block buster drug in the pipeline, SHP it may make sense for Takeda to take SHP over. 5. Takeda research centre is close by to SHP research centre in the USA...saving here... 6. Takeda CEO is ex big Pharma executive . He wants to run a big Pharma not just medium size Takeda. Interesting time ahead.
romeike: @rue most companies have a policy of not commenting on the share price movements unless for some reason they need to issue a statement for regulatory reasons. Uncertainty can be a killer for shares. And there is a lot of uncertainty here since the announcement of the review. Some took it as an admission that Baxalta integration was not going well, but subsequent results have shown that is not the case. Still, the uncertainty remains, much as it does at GSK re: potential Pfizer consumer deal. In both cases the shares have been hammered since the uncertainty became the main focus of the stock. In the case of SHP I think the share price is stuck until the strategy becomes clear. I actually don't mind what they do, but I don't like the way it is being dragged out. I had hoped for clarity before Christmas but the decision has been kicked into H2. I actually think it may have to be resolved sooner - after the next interim results. Investors buying in at current prices could make a very significant return should a split occur, both new co will be prime targets and vulnerable for takeover.
justiceforthemany: As I said before the CEO gave a long interview with the FT a couple of months ago about how 'fed up' he was with the share price and how he felt the market was undervaluing the company. At the time the share price was 4400p. The share price is now 3800p and has been down to 3600p. Competition concerns are vague and unsubstantiated at the moment - only those 'in the know' truly know what is going on behind the scenes. Brokers continue to target as high as 6000p - they are pretty hopeless but this is a huge disparity with the current share price I guess this is what they feel Shire would be worth if someone bid. If he really is as fed up as he seems I doubt he would turn down an offer around 5000p this time. As for GBP vs USD funny how Shire gets hammered more than its peers who also have large earnings in USD.
Shire share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180422 02:46:48